GI Документы SEC - EndoChoice Holdings Inc.- Годовой отчет, доверенное заявление, проспект эмиссии

Основная статистика

CIK

1623919

SEC Filings

All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis. These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to EndoChoice Holdings Inc.

SEC Filings (Chronological Order)

На этой странице представлен полный хронологический список документов SEC, за исключением документов о собственности, которые мы предоставляем в других местах.

February 14, 2017	SC 13G/A	GI / EndoChoice Holdings Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
February 10, 2017	SC 13G/A	GI / EndoChoice Holdings Inc. / SC US GF V Holdings, Ltd. - SCHEDULE 13G [AMENDMENT NO.1] Passive Investment Schedule 13G [Amendment No.1] SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. 1) ENDOCHOICE HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29272U103 (CUSIP Number) 12/31/16 (Date
February 2, 2017	SC 13G/A	GI / EndoChoice Holdings Inc. / ENVEST III LLC - SC 13G/A Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 2)* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) November 22, 2016 (Date of
December 21, 2016	SC 13D/A	GI / EndoChoice Holdings Inc. / U.M. AccelMed, Limited Partnership - SC 13D/A Activist Investment SC 13D/A 1 zk1619306.htm SC 13D/A SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES ACT OF 1934 (Amendment No. 1) EndoChoice Holdings, Inc. (Name of Issuer) Common Stock, $0.001 par value per share 29272U103 (Title of class of securities) (CUSIP number) Uri Geiger U.M. AccelMed, Limited Partnership 6 Hachoshlim St. Herzelia, Israel Telephone: 011-972-9-788-
December 5, 2016	15-12B	EndoChoice Holdings 15-12B 15-12B 1 a16-2253711512b.htm 15-12B UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-37414 EndoChoice Holdings, Inc. (Exa
November 28, 2016	SC 13D/A	GI / EndoChoice Holdings Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to
November 23, 2016	S-8 POS	EndoChoice Holdings S-8 POS As filed with the Securities and Exchange Commission on November 23, 2016 Registration Nos.
November 23, 2016	S-8 POS	EndoChoice Holdings S-8 POS S-8 POS 1 a16-219803s8pos.htm S-8 POS As filed with the Securities and Exchange Commission on November 23, 2016 Registration Nos. 333-204938, 333-211146 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-204938 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-211146 UNDER THE SEC
November 22, 2016	EX-99.25	EX-99.25 NOTIFICATION OF THE REMOVAL FROM LISTING AND REGISTRATION OF THE STATED SECURITIES The New York Stock Exchange hereby notifies the SEC of its intention to remove the entire class of the stated securities from listing and registration on the Exchange at the opening of business on December 5, 2016, pursuant to the provisions of Rule 12d2-2 (a).
November 22, 2016	8-K	Changes in Control of Registrant, Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits, Completion of Acquisition or Disposition of Assets 8-K 1 a16-2198028k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): November 22, 2016 ENDOCHOICE HOLDINGS, INC. (Exact name of registrant as specified in charter) DELAWARE 001-37414 90-0886803 (State or other (Commission (IRS
November 22, 2016	EX-3.2	BYLAWS ENDOCHOICE HOLDINGS, INC. a Delaware Corporation as of November 22, 2016 Exhibit 3.2 BYLAWS of ENDOCHOICE HOLDINGS, INC. a Delaware Corporation as of November 22, 2016 TABLE OF CONTENTS Article I. - General 1 1.1. Offices 1 1.2. Seal 1 1.3. Fiscal Year 1 Article II. - Stockholders 1 2.1. Place of Meetings 1 2.2. Annual Meeting 1 2.3. Quorum 1 2.4. Right to Vote; Proxies 2 2.5. Voting 2 2.6. Notice of Annual Meetings 2 2.7. Stockholders? List 2 2.8. Special Meetings 3 2
November 22, 2016	EX-3.1	CERTIFICATE OF INCORPORATION ENDOCHOICE HOLDINGS, INC. EX-3.1 2 a16-219802ex3d1.htm EX-3.1 Exhibit 3.1 CERTIFICATE OF INCORPORATION OF ENDOCHOICE HOLDINGS, INC. FIRST: The name of the corporation is: EndoChoice Holdings, Inc. SECOND: The address of its registered office in the State of Delaware is 2711 Centerville Road, Suite 400, in the City of Wilmington, County of New Castle, 19808. The name of its registered agent at such address is Corporation Se
November 22, 2016	SC 14D9/A	EndoChoice Holdings SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 5) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 29272U103 (
November 22, 2016	SC TO-T/A	EndoChoice Holdings SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 4) ENDOCHOICE HOLDINGS, INC. (Name of Subject Company (Issuer)) Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation (Names of Filing Persons (Offerors)) Common Stock, $0
November 22, 2016	EX-99.(A)(5)(B)	Boston Scientific Closes EndoChoice Acquisition Acquisition Expands Endoscopy Portfolio EX-99.(A)(5)(B) 2 a16-1957411ex99da5b.htm EX-99.(A)(5)(B) Exhibit (a)(5)(B) Boston Scientific Closes EndoChoice Acquisition Acquisition Expands Endoscopy Portfolio Marlborough, Mass., (TBD) — Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of EndoChoice Holdings, Inc. (NYSE: GI). With the completion of the acquisition, EndoChoice will become part of the Bosto
November 18, 2016	SC TO-T/A	EndoChoice Holdings SC TO-T/A SC TO-T/A 1 a16-1957410sctota.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 3) ENDOCHOICE HOLDINGS, INC. (Name of Subject Company (Issuer)) Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation (Names of
November 18, 2016	SC 14D9/A	EndoChoice Holdings SC 14D9/A SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 4) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 2
November 7, 2016	10-Q	EndoChoice Holdings 10-Q (Quarterly Report) 10-Q 1 a20160930q310-q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2016 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37414 EndoChoi
November 7, 2016	EX-10.1	AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) Exhibit Execution Version AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) This AMENDMENT NO. 1 TO CREDIT AND SECURITY AGREEMENT (TERM LOAN) (this ? Agreement ?) is made as of this 2 nd day of August, 2016, by and among ENDOCHOICE HOLDINGS, INC. (? Holdings ?), ENDOCHOICE, INC. (? Endochoice ?), ROBERT S. SMITH, M.D., INC. (together with Holdings and Endochoice, collectively in the sin
November 7, 2016	EX-10.2	AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) EX-10.2 3 exhibit102-amendmentno2toc.htm EXHIBIT 10.2 Execution Version AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) This AMENDMENT NO. 2 TO CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) (this “Agreement”) is made as of this 2nd day of August, 2016, by and among ENDOCHOICE HOLDINGS, INC. (“Holdings”), ENDOCHOICE, INC. (“Endochoice”), ROBERT S. SMITH, M.D., INC. (together with
November 4, 2016	SC 14D9/A	EndoChoice Holdings SC 14D9/A SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 3) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 2
November 4, 2016	SC TO-T/A	EndoChoice Holdings SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 2) ENDOCHOICE HOLDINGS, INC. (Name of Subject Company (Issuer)) Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation (Names of Filing Persons (Offerors)) Common Stock, $0
November 4, 2016	EX-99.(A)(5)(A)	Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice Exhibit (a)(5)(A) FOR IMMEDIATE RELEASE Boston Scientific Announces Extension of the Cash Tender Offer for All Shares of EndoChoice MARLBOROUGH, Mass.
October 26, 2016	SC 14D9/A	EndoChoice Holdings SC 14D9/A SC 14D9/A 1 d220667dsc14d9a.htm SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 2) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share
October 26, 2016	SC TO-T/A	EndoChoice Holdings SC TO-T/A SC TO-T/A 1 a16-195748sctota.htm SC TO-T/A SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No. 1) ENDOCHOICE HOLDINGS, INC. (Name of Subject Company (Issuer)) Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation (Names of
October 20, 2016	SC 13D	GI / EndoChoice Holdings Inc. / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices an
October 11, 2016	SC 14D9/A	EndoChoice Holdings SC 14D9/A SC 14D9/A 1 d266418dsc14d9a.htm SC 14D9/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Amendment No. 1) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share
October 11, 2016	EX-99.1	GENERAL INFORMATION Question 1: What happens to the ESPP before the merger is completed? Answer 1: No change in the terms and conditions of the ESPP occurred on the date the Company signed the Merger Agreement. Salary deferrals will continue until th EX-99.1 2 d193134dex991.htm EX-99.1 Exhibit 99.1 Date: October 10, 2016 To: ESPP Participants From: Andy Lyness Subject: Treatment of Shares in your EndoChoice Holdings, Inc. Employee Stock Purchase Plan (“ESPP”) Account in Connection with our Merger EndoChoice Holdings, Inc. (the “Company”) has entered into an agreement and plan of merger, dated September 27, 2016 (the “Merger Agreement”), by and
October 11, 2016	SC14D9C	EndoChoice Holdings SC14D9C SC14D9C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 29272U
October 11, 2016	EX-99.2	TREATMENT OF OUTSTANDING EQUITY AWARDS Question 7: Do I need to do anything to receive the cash payment for my equity awards? Answer 7: US participants should review your contact information in ADP to ensure that your home address, email address, pho EX-99.2 3 d193134dex992.htm EX-99.2 Exhibit 99.2 Date: October 10, 2016 To: Associates, Former Associates and Consultants Holding Equity Awards From: Andy Lyness Subject: Treatment of Equity Awards Issued Under the EndoChoice Holdings, Inc. 2015 Equity Incentive Plan (including the Israeli Appendix to such plan), the ECPM Holdings, LLC 2013 Incentive Unit Plan (including the Israeli Appendix to su
October 11, 2016	SC 13G/A	GI / EndoChoice Holdings Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment SC 13G/A 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 2 )* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) September 30, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate
October 7, 2016	EX-99.(E)(5)	BOSTON SCIENTIFIC CORPORATION 300 Boston Scientific Way Marlborough, Massachusetts 01752 September 21, 2016 EX-99.(E)(5) 3 d252984dex99e5.htm EX-99.(E)(5) Exhibit (e)(5) BOSTON SCIENTIFIC CORPORATION 300 Boston Scientific Way Marlborough, Massachusetts 01752 September 21, 2016 EndoChoice Holdings, Inc. c/o Guggenheim Securities, LLC 330 Madison Avenue, 14th Floor New York, NY 10017 Re: Extension of Exclusivity Ladies and Gentlemen: We refer to the indication of interest between Boston Scientific Corpora
October 7, 2016	SC 14D9	EndoChoice Holdings SC 14D9 SC 14D9 Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.
October 7, 2016	EX-99.(E)(4)	-2- EX-99.(E)(4) 2 d252984dex99e4.htm EX-99.(E)(4) Exhibit (e)(4) 300 Boston Scientific Way Marlborough, MA 01752 508-683-5537 Tel 508-683-4380 Fax www.bostonscientific.com September 1, 2016 Strictly Confidential Joseph Kohls Senior Managing Director Guggenheim Securities, LLC 330 Madison Avenue, 14th Floor New York, NY 10017 Dear Joe: Following our most recent discussions, I am pleased to submit, on
October 7, 2016	EX-99.(A)(1)(H)	BOSTON SCIENTIFIC COMMENCES CASH TENDER OFFER FOR ALL SHARES OF ENDOCHOICE FOR $8.00 PER SHARE IN CASH EX-99.(A)(1)(H) 8 a2229959zex-99a1h.htm EX-99.(A)(1)(H) Exhibit (a)(1)(H) NEWS RELEASE BOSTON SCIENTIFIC COMMENCES CASH TENDER OFFER FOR ALL SHARES OF ENDOCHOICE FOR $8.00 PER SHARE IN CASH MARLBOROUGH, MASS. — October 7, 2016 — Boston Scientific Corporation today announced that its wholly-owned merger subsidiary, Falcon Merger Corp., has launched its previously announced tender offer for all shar
October 7, 2016	EX-99.(A)(1)(D)	Offer to Purchase for Cash All Outstanding Shares of Common Stock of ENDOCHOICE HOLDINGS, INC. at $8.00 Net Per Share by Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(D) Offer to Purchase for Cash All Outstanding Shares of Common Stock of ENDOCHOICE HOLDINGS, INC.
October 7, 2016	EX-99.(D)(3)	CONFIDENTIALITY AGREEMENT Exhibit (d)(3) CONFIDENTIALITY AGREEMENT June 6, 2016 Boston Scientific Corporation 100 Boston Scientific Way Marlborough, MA 01752 Attention: David Pierce SVP & President, Endoscopy Ladies and Gentlemen: This agreement (this ?Agreement?) is being entered into in connection with your consideration of a possible negotiated transaction (the ?Transaction?) between EndoChoice Holdings, Inc.
October 7, 2016	EX-99.(A)(1)(A)	Offer to Purchase for Cash All Outstanding Shares of Common Stock of ENDOCHOICE HOLDINGS, INC. at $8.00 Net Per Share by Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation Use these links to rapidly review the document TABLE OF CONTENTS Exhibit (a)(1)(A) Offer to Purchase for Cash All Outstanding Shares of Common Stock of ENDOCHOICE HOLDINGS, INC.
October 7, 2016	EX-99.(A)(1)(C)	Notice of Guaranteed Delivery for Tender of Shares of Common Stock of ENDOCHOICE HOLDINGS, INC. at $8.00 Net Per Share by Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation (Not to be used for Signature Guarantees) QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(C) Notice of Guaranteed Delivery for Tender of Shares of Common Stock of ENDOCHOICE HOLDINGS, INC.
October 7, 2016	EX-99.(A)(1)(B)	Letter of Transmittal to Tender Shares of Common Stock of ENDOCHOICE HOLDINGS, INC. at $8.00 Net Per Share Pursuant to the Offer to Purchase Dated October 7, 2016 by Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporatio EX-99.(A)(1)(B) 3 a2229959zex-99a1b.htm EX-99.(A)(1)(B) QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(B) Letter of Transmittal to Tender Shares of Common Stock of ENDOCHOICE HOLDINGS, INC. at $8.00 Net Per Share Pursuant to the Offer to Purchase Dated October 7, 2016 by Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation THE OFFE
October 7, 2016	SC TO-T	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE TO (Rule 14d-100) TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1) OF THE SECURITIES EXCHANGE ACT OF 1934 ENDOCHOICE HOLDINGS, INC. (Name of Subject Company (Issuer)) Falcon QuickLinks - Click here to rapidly navigate through this document SECURITIES AND EXCHANGE COMMISSION Washington, D.
October 7, 2016	EX-99.(A)(1)(E)	Offer to Purchase for Cash All Outstanding Shares of Common Stock of ENDOCHOICE HOLDINGS, INC. at $8.00 Net Per Share by Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation Exhibit (a)(1)(E) Offer to Purchase for Cash All Outstanding Shares of Common Stock of ENDOCHOICE HOLDINGS, INC.
October 7, 2016	EX-99.(A)(1)(G)	Notice of Offer to Purchase for Cash All Outstanding Shares of Common Stock ENDOCHOICE HOLDINGS, INC. $8.00 Net Per Share Falcon Merger Corp. a direct wholly-owned subsidiary of Boston Scientific Corporation QuickLinks - Click here to rapidly navigate through this document Exhibit (a)(1)(G) This announcement is neither an offer to purchase nor a solicitation of an offer to sell Shares (as defined below).
September 27, 2016	EX-99.2	BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology Portfolio EX-99.2 Exhibit 99.2 BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology Portfolio MARLBOROUGH, Mass. and ALPHARETTA, Ga. (September 27, 2016) ? Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon compl
September 27, 2016	EX-2.1	AGREEMENT AND PLAN OF MERGER by and among BOSTON SCIENTIFIC CORPORATION, FALCON MERGER CORP. ENDOCHOICE HOLDINGS, INC. Dated as of September 27, 2016 TABLE OF CONTENTS Page ARTICLE 1 THE OFFER AND THE MERGER 2 1.1 The Offer 2 1.2 Company Actions 5 1. EX-2.1 2 d267360dex21.htm EX-2.1 Exhibit 2.1 Execution Version AGREEMENT AND PLAN OF MERGER by and among BOSTON SCIENTIFIC CORPORATION, FALCON MERGER CORP. and ENDOCHOICE HOLDINGS, INC. Dated as of September 27, 2016 TABLE OF CONTENTS Page ARTICLE 1 THE OFFER AND THE MERGER 2 1.1 The Offer 2 1.2 Company Actions 5 1.3 The Merger 6 1.4 Closing and Effective Time of the Merger 7 ARTICLE 2 CONVERSION
September 27, 2016	8-K	Regulation FD Disclosure, Entry into a Material Definitive Agreement, Financial Statements and Exhibits UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 27, 2016 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other jurisdiction of incorporation) (Commis
September 27, 2016	EX-99.1	BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology Portfolio Exhibit 99.1 BOSTON SCIENTIFIC TO ACQUIRE ENDOCHOICE Acquisition Will Expand Endoscopy Gastroenterology Portfolio MARLBOROUGH, Mass. and ALPHARETTA, Ga. (September 27, 2016) ? Boston Scientific (NYSE: BSX) and EndoChoice Holdings, Inc. (NYSE: GI) today announced the companies have entered into a definitive agreement under which Boston Scientific has agreed to acquire EndoChoice. Upon completion of
September 27, 2016	SC14D9C	EndoChoice Holdings SC14D9C UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14D-9 (Rule 14d-101) Solicitation/Recommendation Statement Under Section 14(d)(4) of the Securities Exchange Act of 1934 EndoChoice Holdings, Inc. (Name of Subject Company) EndoChoice Holdings, Inc. (Name of Person Filing Statement) Common Stock, $0.001 par value per share (Title of Class of Securities) 29272U103 (CUS
September 27, 2016	EX-99.1	TENDER AND SUPPORT AGREEMENT EX-99.1 Exhibit 99.1 Execution Version TENDER AND SUPPORT AGREEMENT This TENDER AND SUPPORT AGREEMENT (this ?Agreement?), dated as of September 27, 2016, is entered into by and among [ l ] (?Stockholder?), BOSTON SCIENTIFIC CORPORATION, a Delaware corporation (?Parent?), and FALCON MERGER CORP., a Delaware corporation and a subsidiary of Parent (?Purchaser?). WHEREAS, contemporaneously with the ex
September 27, 2016	EX-99.1	EndoChoice Acquisition MANAGER TOOLKIT EX-99.1 2 d253369dex991.htm EX-99.1 Exhibit 99.1 EndoChoice Acquisition MANAGER TOOLKIT September 27, 2016 Intent: The purpose of this document is to provide managers with talking points and responses to frequently asked questions regarding the announcement of the planned acquisition of EndoChoice. This document is for internal use only. Please note that per company policy, all media inquiries for
September 27, 2016	SC TO-C	Boston Scientific 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): September 27, 2016 BOSTON SCIENTIFIC CORPORATION (Exact name of registrant as specified in charter) DELAWARE 1-11083 04-2695240 (State or other (Commission (IRS employer jurisdiction of file number) identification no.
August 9, 2016	SC 13G/A	GI / EndoChoice Holdings Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1 )* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) July 29, 2016 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this
August 8, 2016	CORRESP	EndoChoice Holdings ESP CORRESP 1 filename1.htm [Letterhead of EndoChoice Holdings, Inc.] August 8, 2016 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Re: Acceleration Request for EndoChoice Holdings, Inc. Registration Statement on Form S-3 (File No. 333-212868) Ladies and Gentlemen: Pursuant to Rule 461 under the Securitie
August 3, 2016	EX-99.1	EndoChoice Announces Second Quarter 2016 Financial Results EX-99.1 2 exhibit991-pressreleasedat.htm EXHIBIT 99.1 Exhibit 99.1 EndoChoice Announces Second Quarter 2016 Financial Results Alpharetta, GA, August 3, 2016 - EndoChoice Holdings, Inc. (NYSE: GI) announced today financial results for the second quarter 2016. Highlights • Revenue of $19.3 million, up 3.3% year-over-year • Pathology revenue up 29% year-over-year, driven by 33% specimen growth • Gros
August 3, 2016	8-K	EndoChoice Holdings 8-K (Current Report/Significant Event) Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 3, 2016 EndoChoice Holdings, Inc.
August 3, 2016	EX-25.1	SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE Exhibit 25.1 SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM T-1 STATEMENT OF ELIGIBILITY UNDER THE TRUST INDENTURE ACT OF 1939 OF A CORPORATION DESIGNATED TO ACT AS TRUSTEE ¨ Check if an Application to Determine Eligibility of a Trustee Pursuant to Section 305(b)(2) U.S. BANK NATIONAL ASSOCIATION (Exact name of Trustee as specified in its charter) 31-0841368 I.R.S. Employer Identif
August 3, 2016	EX-4.9	ENDOCHOICE HOLDINGS, INC. U.S. BANK NATIONAL ASSOCIATION, as Trustee DATED AS OF , 2016 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 101. Definitions. 1 SECTION 102. Compliance Certificates and Op EX-4.9 Exhibit 4.9 ENDOCHOICE HOLDINGS, INC. U.S. BANK NATIONAL ASSOCIATION, as Trustee INDENTURE DATED AS OF , 2016 TABLE OF CONTENTS Page ARTICLE 1 DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION 1 SECTION 101. Definitions. 1 SECTION 102. Compliance Certificates and Opinions. 9 SECTION 103. Form of Documents Delivered to Trustee. 10 SECTION 104. Acts of Holders. 10 SECTION 105. Notices,
August 3, 2016	EX-12.1	EndoChoice Holdings, Inc. Computation of Deficiency of Earnings to Fixed Charges Six Months Ended June 30, 2016 Year Ended December 31, in thousands 2015 2014 2013 2012 Earnings (loss): Net loss $ (41,747 ) $ (59,384 ) $ (53,644 ) $ (23,918 ) $ (1,20 EX-12.1 Exhibit 12.1 EndoChoice Holdings, Inc. Computation of Deficiency of Earnings to Fixed Charges Six Months Ended June 30, 2016 Year Ended December 31, in thousands 2015 2014 2013 2012 Earnings (loss): Net loss $ (41,747 ) $ (59,384 ) $ (53,644 ) $ (23,918 ) $ (1,201 ) Fixed charges (from below) 2,554 8,149 4,346 387 386 Total loss $ (39,193 ) $ (51,235 ) $ (49,298 ) $ (23,531 ) $ (815 ) Fixe
August 3, 2016	S-3	EndoChoice Holdings S-3 S-3 Table of Contents As filed with the Securities and Exchange Commission on August 3, 2016.
August 3, 2016	10-Q	EndoChoice Holdings 10-Q (Quarterly Report) 10-Q 1 a20160630q210-q.htm 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2016 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37414 EndoChoice Ho
May 5, 2016	S-8	EndoChoice Holdings S-8 As filed with the Securities and Exchange Commission on May 5, 2016 Registration No.
May 4, 2016	EX-99.1	EndoChoice® Announces William Enquist as New Chairman of the Board Exhibit Exhibit 99.1 EndoChoice? Announces William Enquist as New Chairman of the Board Alpharetta, GA., May 2, 2016 - EndoChoice Holdings, Inc. (NYSE: GI) announced today that existing Board member William (Bill) Enquist has been elevated to the position of Chairman of the Board of Directors. Scott Huennekens, who has served as Chairman since April 2015, will remain on the Board of Directors. Mr.
May 4, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Submission of Matters to a Vote of Security Holders 8-K 1 form8-kforannualmeetingres.htm 8-K - ITEM 5.02, 5.07 AND 9.01 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): April 29, 2016 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414
May 4, 2016	EX-10.1	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Agreement Exhibit ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Agreement This Nonqualified Stock Option Agreement (this ? Agreement ?) is made and entered into as of and between EndoChoice Holdings, Inc., a Delaware corporation (the ? Company ?) and (the ? Participant ?). Grant Date : Exercise Price per Share : Total Shares of Stock Subject to Option : Expiration Da
May 4, 2016	EX-10.6	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Restricted Stock Unit Agreement Exhibit ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Restricted Stock Unit Agreement This Restricted Stock Unit Agreement (this “ Agreement ”) is made and entered into as of (the “ Grant Date ”) by and between EndoChoice Holdings, Inc., a Delaware corporation (the “ Company ”) and (the “ Grantee ”). WHEREAS , the Company has adopted the EndoChoice Holdings, Inc. 2015 Omnibus Equity
May 4, 2016	10-Q	EndoChoice Holdings 10-Q (Quarterly Report) 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2016 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37414 EndoChoice Holdings, Inc. (Exact name o
May 4, 2016	EX-10.4	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Restricted Stock Unit Agreement Exhibit ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Restricted Stock Unit Agreement This Restricted Stock Unit Agreement (this ? Agreement ?) is made and entered into as of (the ? Grant Date ?) by and between EndoChoice Holdings, Inc., a Delaware corporation (the ? Company ?) and (the ? Grantee ?). WHEREAS , the Company has adopted the EndoChoice Holdings, Inc. 2015 Omnibus Equity
May 4, 2016	EX-10.2	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN 102 Capital Gains Track Nonqualified Stock Option Agreement Exhibit ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN 102 Capital Gains Track Nonqualified Stock Option Agreement This Nonqualified Stock Option Agreement (this ? Agreement ?) is made and entered into as of and between EndoChoice Holdings, Inc., a Delaware corporation (the ? Company ?) and (the ? Participant ?). Grant Date : Exercise Price per Share : Total Shares of Stock Subject t
May 4, 2016	EX-10.5	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN 102 Capital Gains Track Restricted Stock Unit Agreement Exhibit ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN 102 Capital Gains Track Restricted Stock Unit Agreement This Restricted Stock Unit Agreement (this “ Agreement” ) is made and entered into as of (the “ Grant Date” ) by and between EndoChoice Holdings, Inc., a Delaware corporation (the “ Company” ) and (the “ Grantee” ). WHEREAS , the Company has adopted the EndoChoice Holdings,
May 4, 2016	EX-10.3	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Agreement EX-10.3 4 exhibit103-nqstockoptionag.htm EXHIBIT 10.3 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Agreement This Nonqualified Stock Option Agreement (this “Agreement”) is made and entered into as of and between EndoChoice Holdings, Inc., a Delaware corporation (the “Company”) and (the “Participant”). Grant Date: Exercise Price per Share: Total Shares of S
May 4, 2016	8-K	Current Report 8-K 1 a20160331earningsrelease8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 4, 2016 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other juri
May 4, 2016	EX-10.7	ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN Originally Effective as of May 22, 2015, and Amended and Restated Effective as of April 29, 2016 ENDOCHOICE HOLDINGS, INC. AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN Originally Effective as of May 22, 2015, and Amended and Restated Effective as of April 29, 2016 ENDOCHOICE HOLDINGS, INC. AMENDED AND RESTATED EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN 1.1 Purpose and Scope. The purpose of the EndoChoice Holdings, Inc. Employee Stock Purchase Plan, as it may be amen
May 4, 2016	EX-99.1	EndoChoice Announces First Quarter 2016 Financial Results EX-99.1 2 exhibit991-pressreleasedat.htm EXHIBIT 99.1 Exhibit 99.1 EndoChoice Announces First Quarter 2016 Financial Results Alpharetta, GA, May 4, 2016 - EndoChoice Holdings, Inc. (NYSE: GI) announced today financial results for the first quarter 2016. Highlights • Revenue of $18.5 million, up 10% year-over-year • Shipped 30 Fuse® Systems including Company records of 29 end-user systems and 19 do
March 21, 2016	DEF 14A	EndoChoice Holdings DEF 14A DEF 14A 1 ech2016proxystmt.htm DEF 14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confidential, for Use of the Commission Only (as
March 21, 2016	10-K	EndoChoice Holdings 10-K (Annual Report) 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2015 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37414 EndoChoice Holdings, Inc. (Exact name of Reg
March 21, 2016	EX-10.24	ENDOCHOICE HOLDINGS, INC. ISRAELI APPENDIX TO Employee Stock Purchase Plan ENDOCHOICE HOLDINGS, INC. ISRAELI APPENDIX TO Employee Stock Purchase Plan 1. Special Provisions for Persons who are Israeli Taxpayers 1.1 This Appendix (the “Appendix”) to the EndoChoice Holdings, Inc. Employee Stock Purchase Plan (the “Plan”) is made and entered effective as of November 30, 2015 (the “Effective Date”). 1.2 The provisions specified hereunder apply only to persons who are subject
March 21, 2016	EX-24.1	POWER OF ATTORNEY POWER OF ATTORNEY KNOW ALL MEN BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Mark G.
March 21, 2016	EX-21.1	LIST OF SUBSIDIARIES OF ENDOCHOICE HOLDINGS, INC. Subsidiary Jurisdiction of Incorporation or Organization EndoChoice, Inc. Delaware EndoChoice GmbH Germany EndoChoice Innovation Center Ltd. Israel Robert S. Smith, M.D., Inc. Georgia EndoChoice Israe LIST OF SUBSIDIARIES OF ENDOCHOICE HOLDINGS, INC. Subsidiary Jurisdiction of Incorporation or Organization EndoChoice, Inc. Delaware EndoChoice GmbH Germany EndoChoice Innovation Center Ltd. Israel Robert S. Smith, M.D., Inc. Georgia EndoChoice Israel Ltd. Israel
March 21, 2016	EX-10.28	AMENDED AND RESTATED EMPLOYMENT AGREEMENT EXECUTION COPY AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made by and amongst ENDOCHOICE HOLDINGS, INC.
March 3, 2016	EX-99.1	EndoChoice Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Guidance for 2016 EX-99.1 Exhibit 99.1 EndoChoice Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Guidance for 2016 Alpharetta, GA, March 3, 2016 ? EndoChoice Holdings, Inc. (NYSE: GI) announced today financial results for the fourth quarter and full year 2015. 2015 Highlights ? Revenue of $72.3 million, up 18% year-over-year (20% in constant currency) ? Installed base of Fuse? reaches 12
March 3, 2016	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Financial Statements and Exhibits, Results of Operations and Financial Condition UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 3, 2016 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other jurisdiction of incorporation) (Commission
February 24, 2016	SC 13G	GI / EndoChoice Holdings Inc. / River Cities Capital Fund IV, L.P. - SC 13G Passive Investment SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to wh
February 19, 2016	SC 13G	EndoChoice Holdings SC 13G (Passive Acquisition of More Than 5% of Shares) SC 13G 1 d146759dsc13g.htm SC 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to design
February 16, 2016	SC 13G/A	GI / EndoChoice Holdings Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
February 16, 2016	SC 13G/A	EndoChoice Holdings SC 13G/A (Passive Acquisition of More Than 5% of Shares) SC 13G/A 1 v431938sc13ga.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G/A (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO § 240.13d-1(b), (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO § 240.13d-2 (Amendment No. 1)* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CU
February 12, 2016	SC 13G	GI / EndoChoice Holdings Inc. / SC US GF V Holdings, Ltd. - SCHEDULE 13G Passive Investment Schedule 13G SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. ) ENDOCHOICE HOLDINGS, INC. (Name of Issuer) COMMON STOCK (Title of Class of Securities) 29272U103 (CUSIP Number) 12/31/15 (Date of Event Which Req
February 11, 2016	SC 13G	GI / EndoChoice Holdings Inc. / Wellington Management Group LLP - SEC SCHEDULE 13G Passive Investment SC 13G 1 SEC13GFiling.htm SEC SCHEDULE 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. )* EndoChoice Holdings, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29272U103 (CUSIP Number) December 31, 2015 (Date of Event Which Requires Filing of this Statement) Check the appropriate box
January 8, 2016	EX-99.1	EndoChoice Announces Preliminary Fourth Quarter and Full Year 2015 Revenue Provides 2016 Revenue Guidance EX-99.1 Exhibit 99.1 EndoChoice Announces Preliminary Fourth Quarter and Full Year 2015 Revenue Provides 2016 Revenue Guidance Alpharetta, GA, January 8, 2016 ? EndoChoice Holdings, Inc. (NYSE: GI) announced today preliminary, unaudited fourth quarter and full year 2015 revenue results. Total revenue for the fourth quarter 2015 is expected to be approximately $18.6 million, compared to $18.3 milli
January 8, 2016	8-K	Current Report 8-K 1 d118439d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 8, 2016 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other jurisdictio
November 20, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer, the General Counsel and the Assistant Corporate Secretary of EndoChoice Holdings, Inc.
November 20, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer, the General Counsel and the Assistant Corporate Secretary of EndoChoice Holdings, Inc.
November 10, 2015	8-K/A	Current Report 8-K/A 1 d94036d8ka.htm 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A (Amendment No. 1) CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 9, 2015 (September 9, 2015) EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-374
November 5, 2015	EX-99.1	EndoChoice Announces Third Quarter 2015 Financial Results Exhibit Exhibit 99.1 EndoChoice Announces Third Quarter 2015 Financial Results Alpharetta, GA, November 5, 2015 - EndoChoice Holdings, Inc. (NYSE: GI) announced today financial results for the third quarter 2015. Highlights ? Total revenue of $18.4 million, up 30% year-over-year (32% in constant currency) ? Installed base of Fuse? now exceeds 100 systems ? Pathology revenue accelerating; 23% growt
November 5, 2015	8-K	Regulation FD Disclosure 8-K 1 d95598d8k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2015 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other jurisdiction of
November 5, 2015	EX-99.1	Safe Harbor This presentation contains forward‐looking statements. You should not rely upon forward‐looking statements as predictions of future events. All statements other than statements of historical facts contained in this presentation, including EX-99.1 Mark Gilreath Founder & CEO David Gill Chief Financial Officer A Platform GI Company November 2015 Exhibit 99.1 Safe Harbor This presentation contains forward?looking statements. You should not rely upon forward?looking statements as predictions of future events. All statements other than statements of historical facts contained in this presentation, including information concerning our po
November 5, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2015 Or ? TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37414 EndoChoice Holdings, Inc. (Exact name of
November 5, 2015	EX-10.1	ENDOCHOICE HOLDINGS, INC. ISRAELI APPENDIX TO 2015 OMNIBUS EQUITY INCENTIVE PLAN ENDOCHOICE HOLDINGS, INC. ISRAELI APPENDIX TO 2015 OMNIBUS EQUITY INCENTIVE PLAN ENDOCHOICE HOLDINGS, INC. ISRAELI APPENDIX TO 2015 OMNIBUS EQUITY INCENTIVE PLAN ENDOCHOICE HOLDINGS, INC. ISRAELI APPENDIX TO 2015 OMNIBUS EQUITY INCENTIVE PLAN 1. Special Provisions for Persons who are Israeli Taxpayers 1.1 This Appendix (the ?Appendix?) to the EndoChoice Holdings, Inc. 2015 Omnibus Equity Incentive Plan (the ?Plan?) is made and entered effective as of September 23, 2015 (the ?E
November 5, 2015	8-K	Current Report UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): November 5, 2015 EndoChoice Holdings, Inc.
September 9, 2015	EX-99.1	EndoChoice® Announces Bill Enquist and Dave Mowry Join Board of Directors Executives Add Significant Medical Device Industry Experience to the Board EX-99.1 Exhibit 99.1 EndoChoice? Announces Bill Enquist and Dave Mowry Join Board of Directors Executives Add Significant Medical Device Industry Experience to the Board Alpharetta, GA., September 9, 2015 /PRNewswire/ ? EndoChoice Holdings, Inc. (NYSE: GI) announced today that William (Bill) R. Enquist, former President of Global Endoscopy for Stryker Corporation (NYSE: SYK), and David (Dave) H. M
September 9, 2015	8-K	Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers, Entry into a Material Definitive Agreement 8-K 1 d15367d8k.htm FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 9, 2015 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other jurisdicti
August 6, 2015	10-Q	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2015 Or ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission file number 001-37414 EndoChoice Holdings, Inc. (Exact name of Regi
August 6, 2015	EX-3.1	CERTIFICATE OF INCORPORATION ENDOCHOICE HOLDINGS, INC. ARTICLE I - NAME CERTIFICATE OF INCORPORATION OF ENDOCHOICE HOLDINGS, INC. ARTICLE I - NAME The name of the corporation is EndoChoice Holdings, Inc. (the “Corporation”). ARTICLE II - REGISTERED OFFICE AND AGENT The address of the Corporation’s registered office in the State of Delaware is Corporation Trust Center, 1209 Orange Street, in the County of New Castle, City of Wilmington, Delaware 19801. The name of the
August 6, 2015	EX-3.2	BYLAWS ENDOCHOICE HOLDINGS, INC. ARTICLE 1 - OFFICES BYLAWS OF ENDOCHOICE HOLDINGS, INC. ARTICLE 1 - OFFICES Section 1.1. Registered Office. The registered office of EndoChoice Holdings, Inc., a Delaware corporation (the “Corporation”), shall be in the County of New Castle, State of Delaware. Section 1.2. Other Offices. The Corporation may also have offices at such other places, either within or outside of the State of Delaware, as the Board of Dire
August 6, 2015	EX-10.12	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Agreement ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Nonqualified Stock Option Agreement This Nonqualified Stock Option Agreement (this “Agreement”) is made and entered into as of [DATE] by and between EndoChoice Holdings, Inc., a Delaware corporation (the “Company”) and [NAME] (the “Participant”). Grant Date: Exercise Price per Share: Total Shares of Stock Subject to Option: Expiration Da
August 6, 2015	8-K	Current Report 8-K 1 a20150630earningsrelease8-k.htm 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 6, 2015 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other j
August 6, 2015	EX-99.1	EndoChoice Announces Second Quarter 2015 Financial Results Imaging revenue up 77% year-over-year EX-99.1 2 a991pressreleasedatedaugus.htm EXHIBIT 99.1 Exhibit 99.1 EndoChoice Announces Second Quarter 2015 Financial Results Imaging revenue up 77% year-over-year Alpharetta, GA, August 6, 2015 /PRNewswire/ - EndoChoice Holdings, Inc. (NYSE: GI) announced today financial results for the second quarter 2015. Highlights • Total revenue of $18.6 million, up 27% year-over-year, before currency impact
July 2, 2015	EX-10.2	CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) dated as of June 30, 2015 by and among ENDOCHOICE HOLDINGS, INC. ENDOCHOICE, INC. ROBERT S. SMITH, M.D., INC. and any additional borrower that hereafter becomes party hereto, each as Borrower, and collec Exhibit 10.2 CREDIT AND SECURITY AGREEMENT (REVOLVING LOAN) dated as of June 30, 2015 by and among ENDOCHOICE HOLDINGS, INC. ENDOCHOICE, INC. ROBERT S. SMITH, M.D., INC. and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FINANCIAL TRUST, as Administrative Agent and as a Lender, and THE ADDITIONAL LENDERS FROM TIME TO TIME PA
July 2, 2015	EX-10.1	CREDIT AND SECURITY AGREEMENT (TERM LOAN) dated as of June 30, 2015 by and among ENDOCHOICE HOLDINGS, INC. ENDOCHOICE, INC. ROBERT S. SMITH, M.D., INC. and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectivel EX-10.1 Exhibit 10.1 CREDIT AND SECURITY AGREEMENT (TERM LOAN) dated as of June 30, 2015 by and among ENDOCHOICE HOLDINGS, INC. ENDOCHOICE, INC. ROBERT S. SMITH, M.D., INC. and any additional borrower that hereafter becomes party hereto, each as Borrower, and collectively as Borrowers, and MIDCAP FINANCIAL TRUST, as Administrative Agent, and THE LENDERS FROM TIME TO TIME PARTY HERETO CREDIT AND SE
July 2, 2015	EX-99.1	EndoChoice® Announces Debt Refinancing Move Strengthens Cash Position, Expands Borrowing Capacity and Reduces Cost of Debt Exhibit 99.1 EndoChoice? Announces Debt Refinancing Move Strengthens Cash Position, Expands Borrowing Capacity and Reduces Cost of Debt Alpharetta, GA., June 30, 2015 /PRNewswire/ ? EndoChoice Holdings, Inc. (NYSE: GI) announced today that it has completed the refinancing of its outstanding debt and closed on a new $58 million senior secured credit facility with Midcap Financial and Silicon Valley
July 2, 2015	8-K	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 30, 2015 EndoChoice Holdings, FORM 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) June 30, 2015 EndoChoice Holdings, Inc. (Exact name of registrant as specified in its charter) Delaware 001-37414 90-0886803 (State or other jurisdiction of incorporation) (Co
June 24, 2015	SC 13G/A	GI / EndoChoice Holdings Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
June 22, 2015	SC 13G	GI / EndoChoice Holdings Inc. / Flynn James E Passive Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1(b)(c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(b) (Amendment No.
June 15, 2015	SC 13D	GI / EndoChoice Holdings Inc. / U.M. AccelMed, Limited Partnership - SC 13D Activist Investment SECURITIES AND EXCHANGE COMMISSION WASHINGTON D.C. 20549 SCHEDULE 13D UNDER THE SECURITIES ACT OF 1934 (Amendment No. ) EndoChoice Holdings, Inc. (Name of Issuer) Common Stock, $0.001 par value per share 29272U103 (Title of class of securities) (CUSIP number) Uri Geiger U.M. AccelMed, Limited Partnership 6 Hachoshlim St. Herzelia, Israel Telephone: 011-972-9-788-3330 (Name, Address and Telephone N
June 15, 2015	EX-99	JOINT FILING AGREEMENT Exhibit 1 JOINT FILING AGREEMENT Pursuant to Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the undersigned hereby agree that only one statement containing the information required by Schedule 13D need be filed with respect to the ownership by each of the undersigned of shares of EndoChoice Holdings, Inc.
June 12, 2015	EX-10.1	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Effective as of May 22, 2015 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN TABLE OF CONTENTS ARTICLE I. ESTABLISHMENT; PURPOSES; AND DURATION 1 1.1. Establishment of the Plan EX-10.1 Exhibit 10.1 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Effective as of May 22, 2015 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN TABLE OF CONTENTS ARTICLE I. ESTABLISHMENT; PURPOSES; AND DURATION 1 1.1. Establishment of the Plan 1 1.2. Purposes of the Plan 1 1.3. Duration of the Plan 1 ARTICLE II. DEFINITIONS 1 2.1. ?Affiliate? 1 2.2. ?Applicable Exchange
June 12, 2015	EX-10.5	PEER MEDICAL LTD. 2010 ISRAELI SHARE OPTION PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) PEER MEDICAL LTD. 2010 ISRAELI SHARE OPTION PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effecti EX-10.5 Exhibit 10.5 PEER MEDICAL LTD. 2010 ISRAELI SHARE OPTION PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) PEER MEDICAL LTD. 2010 ISRAELI SHARE OPTION PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) 1. PURPOSE The purpose of this Share Option Plan is to secure for the Company and its shareholders the benefi
June 12, 2015	EX-10.6	2014 DECLARATION OF AMENDMENT TO PEER MEDICAL LTD. 2010 ISRAELI SHARE OPTION PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) EX-10.6 6 d935339dex106.htm EX-10.6 Exhibit 10.6 2014 DECLARATION OF AMENDMENT TO PEER MEDICAL LTD. 2010 ISRAELI SHARE OPTION PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) THIS 2014 DECLARATION OF AMENDMENT, is made by ECPM Holdings, LLC, a Delaware limited liability company (the “Company”), effective as of the 6th day of August, 2014, to the Peer Medic
June 12, 2015	EX-10.4	ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN Effective as of May 22, 2015 ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN TABLE OF CONTENTS ARTICLE I PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN 4 1.1. Purpose and Scope 4 ARTICLE II EX-10.4 Exhibit 10.4 ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN Effective as of May 22, 2015 ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN TABLE OF CONTENTS ARTICLE I PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN 4 1.1. Purpose and Scope 4 ARTICLE II DEFINITIONS 4 2.1. ?Agent? 4 2.2. ?Administrator? 4 2.3. ?Board? 4 2.4. ?Code? 4 2.5. ?Committee? 4 2.6. ?Common Stock? 4 2.7. ?
June 12, 2015	S-8	EndoChoice Holdings S-8 As filed with the Securities and Exchange Commission on June 12 , 2015 Registration No.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24.1	EX-24.1 LIMITED POWER OF ATTORNEY FOR SECTION 16(a) FILINGS Know all by these presents, that the undersigned hereby constitutes and appoints Melinda Dunn the undersigned's true and lawful attorney-in-fact to: (1) Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or stockholder of any corporation or other person in which an investment fund affiliated wi
June 5, 2015	EX-24.1	EX-24.1 EX-24.1 2 attachment1.htm EX-24.1 DOCUMENT LIMITED POWER OF ATTORNEY FOR SECTION 16(a) FILINGS Know all by these presents, that the undersigned hereby constitutes and appoints Melinda Dunn the undersigned's true and lawful attorney-in-fact to: (1) Execute for and on behalf of the undersigned, in the undersigned's capacity as an officer, director and/or stockholder of any corporation or other perso
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	POS AM	EndoChoice Holdings POS AM POS AM As filed with the Securities and Exchange Commission on June 4, 2015. Registration No. 333-203883 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Post-Effective Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ECPM HOLDINGS, LLC to be converted as described herein to a corporation named EndoChoice Holdings, Inc. (Exact name of Regis
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	8-A12B	EndoChoice Holdings FORM 8-A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-A FOR REGISTRATION OF CERTAIN CLASSES OF SECURITIES PURSUANT TO SECTION 12(b) OR 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 ENDOCHOICE HOLDINGS, INC.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	EX-24	EX-24 POWER OF ATTORNEY FOR SECTION 16 REPORTING OBLIGATIONS KNOW ALL BY THESE PRESENTS, that the undersigned hereby makes, constitutes and appoints the Chief Financial Officer and the General Counsel of EndoChoice Holdings, Inc.
June 5, 2015	424B4	6,350,000 Shares Common Stock 424B4 Table of Contents Filed pursuant to Rule 424(b)(4) Registration No. 333-203883 PROSPECTUS 6,350,000 Shares Common Stock This is an initial public offering of shares of common stock by EndoChoice Holdings, Inc. Prior to this offering, there has been no public market for our common stock. We are offering 6,350,000 shares to be sold in the offering. Our common stock has been approved for listin
June 3, 2015	CORRESP	EndoChoice Holdings ESP CORRESP 1 filename1.htm King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M. Townsend Direct Dial: (404) 572-3517 Direct Fax: (404) 572-5100 [email protected] June 3, 2015 Via EDGAR Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Attn: Ms. Amanda Ravitz, Assis
June 3, 2015	S-1/A	EndoChoice Holdings FORM S-1/A S-1/A 1 d829480ds1a.htm FORM S-1/A As filed with the Securities and Exchange Commission on June 3, 2015. Registration No. 333-203883 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 3 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ECPM HOLDINGS, LLC to be converted as described herein to a corporation named EndoChoice Holdings, Inc. (Exact
June 2, 2015	CORRESP	EndoChoice Holdings ESP CORRESP 1 filename1.htm June 2, 2015 Via E-mail and EDGAR United States Securities and Exchange Commission Division of Corporation Finance 100 F. Street, N.E. Washington, D.C. 20549 Attention: Amanda Ravitz Re: Acceleration Request for ECPM Holdings, LLC Registration Statement on Form S-1 (File No. 333-203883) Ladies and Gentlemen: Pursuant to Rule 461 under the Securities Act of 1933, as amended,
June 2, 2015	FWP	Filed Pursuant to Rule 433 FWP Filed Pursuant to Rule 433 Issuer Free Writing Prospectus Dated June 2, 2015 Relating to Preliminary Prospectus Dated May 26, 2015 Registration Statement No.
May 26, 2015	EX-10.4	FIRST AMENDMENT REGISTRATION AGREEMENT EXHIBIT 10.4 FIRST AMENDMENT TO REGISTRATION AGREEMENT This First Amendment to Registration Agreement (this ?Amendment?), is made and entered into effective as of October 30, 2014 (the ?Effective Date?), and amends that certain Registration Agreement, dated as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), and the other parties thereto (t
May 26, 2015	EX-10.3	REGISTRATION AGREEMENT EXHIBIT 10.3 REGISTRATION AGREEMENT THIS REGISTRATION AGREEMENT (this ?Agreement?) is made as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware corporation (the ?Company?), the Persons listed on the Schedule of Investors attached hereto (each, an ?Investor? and collectively, the ?Investors? and the Persons listed on the Schedule of Other Holders attached hereto (each, an ?Other Holde
May 26, 2015	EX-10.14	ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Incentive Option Date Vesting Begins: Expiration Date: , 20 EXHIBIT 10.14 Option No. ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement (Employees) Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Incentive Option Date Vesting Begins: Expiration Date: , 20 THIS AGREEMENT (together with Schedule A attached hereto, this ?Agreement?), made effective as of the day of , 200 (the ?Grant Dat
May 26, 2015	EX-10.1	ECPM HOLDINGS, LLC A Delaware Limited Liability Company SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of March 4, 2015 EXHIBIT 10.1 ECPM HOLDINGS, LLC A Delaware Limited Liability Company SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of March 4, 2015 THE MEMBERSHIP UNITS REPRESENTED BY THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE FEDERAL OR STATE SECU
May 26, 2015	EX-10.11	PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT Exhibit 10.11 PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT This is a PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT dated as of February 18, 2014 by and between ENDOCHOICE, INC., a Delaware corporation (?EC INC?), ECPM HOLDINGS, LLC, a Delaware limited liability company (?HOLDINGS?), ENDOCHOICE INTERNATIONAL, LLC, a Georgia limited liability company (?EC INT?L?), ROBERT S. SM
May 26, 2015	EX-10.7	LOAN AND SECURITY AGREEMENT Exhibit 10.7 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (this ?Agreement?) dated as of September 9, 2013 (the ?Effective Date?) between (i) SILICON VALLEY BANK, a California corporation (?Bank?), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (?Holdings?) and (iii) ENDOCHOICE, INC., a Delaware corporation (?EndoChoice?), ENDOCHOICE INTERNATIONAL, LLC, a Georgia lim
May 26, 2015	EX-21.1	List of Subsidiaries of ECPM Holdings, LLC Subsidiary Jurisdiction of Incorporation or Organization EndoChoice, Inc. Delaware EndoChoice GmbH Germany EndoChoice Innovation Center Ltd. Israel Robert S. Smith, M.D., Inc. Georgia EndoChoice Israel Ltd. EXHIBIT 21.1 List of Subsidiaries of ECPM Holdings, LLC Subsidiary Jurisdiction of Incorporation or Organization EndoChoice, Inc. Delaware EndoChoice GmbH Germany EndoChoice Innovation Center Ltd. Israel Robert S. Smith, M.D., Inc. Georgia EndoChoice Israel Ltd. Israel
May 26, 2015	EX-10.15	ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement (Non-Employee Directors) Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Nonqualified Option Date Vesting Begins: Expiration EXHIBIT 10.15 Option No. ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement (Non-Employee Directors) Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Nonqualified Option Date Vesting Begins: Expiration Date: , 20 THIS AGREEMENT (together with Schedule A attached hereto, this ?Agreement?), made effective as of the day of , 200
May 26, 2015	EX-10.20	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Section 3(i) Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units EXHIBIT 10.20 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Section 3(i) Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units THIS INCENTIVE UNIT AWARD AGREEMENT (the ?Agreement?), made effective as of the day of , 20 (the ?Grant Date?), between ECPM HOLDINGS, LLC, a Delaware limited liability company (the ?Company?), and , a Con
May 26, 2015	EX-10.16	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN EXHIBIT 10.16 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN 1. Definitions In addition to other terms which may be defined herein, the following terms shall have the meanings given below: (a) Administrator means the Board of the Company, and, upon its delegation of all or part of the authority to administer the Plan to the Committee, the Committee. (b) Aff
May 26, 2015	EX-10.17	FIRST AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN EXHIBIT 10.17 FIRST AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN THIS FIRST AMENDMENT, is made by ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), effective as of the 9th day of September, 2013, to the Company?s 2013 Incentive Unit Plan, dated effective as of January 11, 2013 (the ?Plan?). Capitalized terms used herein and not otherwise defined shall have the m
May 26, 2015	EX-10.19	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units EX-10.19 23 d829480dex1019.htm EX-10.19 EXHIBIT 10.19 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units THIS INCENTIVE UNIT AWARD AGREEMENT (the “Agreement”), made effective as of the day of , 20 (the “Grant Date”), between ECPM HOLDINGS, LLC, a Delaware limited liability company (
May 26, 2015	EX-1.1	ECPM Holdings, LLC [●] Shares of Common Stock, par value $0.001 per share Underwriting Agreement Exhibit 1.1 ECPM Holdings, LLC [?] Shares of Common Stock, par value $0.001 per share Underwriting Agreement , 2015 J. P. Morgan Securities LLC Merrill Lynch, Pierce, Fenner & Smith Incorporated As Representatives of the several Underwriters listed in Schedule 1 hereto c/o J. P. Morgan Securities LLC 383 Madison Avenue New York, New York 10179 c/o Merrill Lynch, Pierce, Fenner & Smith Incorporated
May 26, 2015	S-1/A	As filed with the Securities and Exchange Commission on May 26, 2015. S-1/A 1 d829480ds1a.htm FORM S-1/A Table of Contents Index to Financial Statements As filed with the Securities and Exchange Commission on May 26, 2015. Registration No. 333-203883 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 2 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ECPM HOLDINGS, LLC to be converted as described herein to a cor
May 26, 2015	EX-16.1	WINDHAM BRANNON EXHIBIT 16.1 WINDHAM BRANNON January 9, 2015 Securities and Exchange Commission Mail Stop 8031 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We were previously principal accountants for EndoChoice, Inc. and Subsidiaries (predecessor to ECPM Holdings, LLC) and, under the date of July 30, 2013, we reported on the consolidated financial statements of EndoChoice, Inc. and Subsidiaries as
May 26, 2015	EX-10.10	THIRD LOAN MODIFICATION AND WAIVER AGREEMENT EXHIBIT 10.10 THIRD LOAN MODIFICATION AND WAIVER AGREEMENT This Third Loan Modification and Waiver Agreement (this ?Loan Modification Agreement?) is entered into as of December 31, 2014 by and between (i) SILICON VALLEY BANK, a California corporation (?Bank?), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (?Holdings?), (iii) ENDOCHOICE, INC., a Delaware corporation (?EndoChoice?),
May 26, 2015	EX-10.2	INVESTOR RIGHTS AGREEMENT EXHIBIT 10.2 INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (this ?Agreement?) is made as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), Avraham Levy (?Levy?) and the Persons listed on the Schedule of Major Members attached hereto (each, a ?Major Member? and collectively, the ?Major Members?). WHEREAS, the Company and certain of
May 26, 2015	EX-10.13	ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed By ECPM Holdings, LLC and Amended and Restated Effective January 4 EXHIBIT 10.13 ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed By ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) 1. Definitions In addition to other terms defined herein, the following terms shall have the meanings given below: (a) Administr
May 26, 2015	EX-4.1	ENDOCHOICE HOLDINGS, INC. a Delaware Corporation Incorporated on , 2015 Common Stock Par Value: $0.001 Exhibit 4.1 Number CS- * * Shares Common Stock ENDOCHOICE HOLDINGS, INC. a Delaware Corporation Incorporated on , 2015 Common Stock Par Value: $0.001 THIS CERTIFIES THAT is the record holder of ( ) shares of Common Stock of EndoChoice Holdings, Inc., a Delaware corporation (the ?Corporation?), transferable only on the books of the Corporation by the holder, in person, or by duly authorized attorne
May 26, 2015	EX-10.8	FIRST LOAN MODIFICATION AND WAIVER AGREEMENT EXHIBIT 10.8 FIRST LOAN MODIFICATION AND WAIVER AGREEMENT This First Loan Modification and Waiver Agreement (this ?Loan Modification Agreement?) is entered into as of March 25, 2014 by and between (i) SILICON VALLEY BANK, a California corporation (?Bank?), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (?Holdings?), (iii) ENDOCHOICE, INC., a Delaware corporation (?EndoChoice?), (iv)
May 26, 2015	EX-10.6	VOTING AGREEMENT EXHIBIT 10.6 VOTING AGREEMENT THIS VOTING AGREEMENT is made and entered into as of this 4th day of January, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), Council Capital II, LP, Envest III, LLC, River Cities Capital Fund IV, L.P., and River Cities Capital Fund IV (N.Q.P.), L.P. (each a ?Class B Holder? and together with any subsequent transferees, who
May 26, 2015	EX-10.21	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN 102 Capital Gains Track Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units EXHIBIT 10.21 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN 102 Capital Gains Track Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units THIS INCENTIVE UNIT AWARD AGREEMENT (the ?Agreement?), made effective as of the day of , 20 (the ?Grant Date?), between ECPM HOLDINGS, LLC, a Delaware limited liability company (the ?Company?),
May 26, 2015	EX-10.9	SECOND LOAN MODIFICATION AND WAIVER AGREEMENT EXHIBIT 10.9 SECOND LOAN MODIFICATION AND WAIVER AGREEMENT This Second Loan Modification and Waiver Agreement (this ?Loan Modification Agreement?) is entered into as of July 24, 2014 by and between (i) SILICON VALLEY BANK, a California corporation (?Bank?), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (?Holdings?), (iii) ENDOCHOICE, INC., a Delaware corporation (?EndoChoice?), and
May 26, 2015	EX-10.18	SECOND AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN EXHIBIT 10.18 SECOND AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN THIS SECOND AMENDMENT, is made by ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), effective as of the 6th day of August, 2014, to the Company?s 2013 Incentive Unit Plan, as amended through September 9, 2013 (the ?Plan?). Capitalized terms used herein and not otherwise defined shall have the mean
May 26, 2015	EX-10.5	SECOND AMENDMENT REGISTRATION AGREEMENT EXHIBIT 10.5 SECOND AMENDMENT TO REGISTRATION AGREEMENT This Second Amendment to Registration Agreement (this ?Amendment?), is made and entered into effective as of March 4, 2015 (the ?Effective Date?), and amends that certain Registration Agreement, dated as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), and the other parties thereto, as
May 26, 2015	EX-10.12	[THE REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK.] EXHIBIT 10.12 May 21, 2015 EndoChoice Holdings, LLC 11810 Wills Road Alpharetta, GA 30009 Attn: David Gill, Chief Financial Officer Dear Mr. Gill, EndoChoice Holdings, LLC (sometimes referred to herein as ?you? or ?Parent?, and collectively with Parent?s direct and indirect domestic subsidiaries, EndoChoice, Inc. and Robert S. Smith, MD, Inc., ?Borrower?) has advised MidCap Financial Services, LLC
May 19, 2015	CORRESP	EndoChoice Holdings ESP CORRESP 1 filename1.htm CONFIDENTIAL TREATMENT REQUEST King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M. Townsend Direct Dial: (404) 572-3517 Direct Fax: (404) 572-5100 [email protected] May 19, 2015 Via EDGAR, E-mail and Overnight Delivery Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Stre
May 18, 2015	CORRESP	EndoChoice Holdings ESP CORRESP 1 filename1.htm King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M. Townsend Direct Dial: (404) 572-3517 Direct Fax: (404) 572-5100 [email protected] May 18, 2015 Via EDGAR, E-mail and Overnight Delivery Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549
May 18, 2015	CORRESP	May 18, 2015 King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M.
May 18, 2015	EX-3.1	FORM OF CERTIFICATE OF INCORPORATION ENDOCHOICE HOLDINGS, INC. ARTICLE I - NAME EXHIBIT 3.1 FORM OF CERTIFICATE OF INCORPORATION OF ENDOCHOICE HOLDINGS, INC. ARTICLE I - NAME The name of the corporation is EndoChoice Holdings, Inc. (the ?Corporation?). ARTICLE II - REGISTERED OFFICE AND AGENT The address of the Corporation?s registered office in the State of Delaware is [ ]. The name of the Corporation?s registered agent at such address is [ ]. ARTICLE III - PURPOSE The purpo
May 18, 2015	S-1/A	As filed with the Securities and Exchange Commission on May 18, 2015. S-1/A 1 d829480ds1a.htm S-1/A Table of Contents As filed with the Securities and Exchange Commission on May 18, 2015. Registration No. 333-203883 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 ECPM HOLDINGS, LLC to be converted as described herein to a corporation named EndoChoice Holdings,
May 5, 2015	S-1	As filed with the Securities and Exchange Commission on May 5, 2015. S-1 Table of Contents As filed with the Securities and Exchange Commission on May 5, 2015.
May 5, 2015	EX-10.30	FORM OF INDEMNIFICATION AGREEMENT Exhibit 10.30 FORM OF INDEMNIFICATION AGREEMENT This INDEMNIFICATION AGREEMENT is made and executed effective as of this day of , 2015, by and between ENDOCHOICE HOLDINGS, INC., a Delaware corporation (the ?Company?), and , an individual resident of the State of (the ?Indemnitee?). WHEREAS, the Company is aware that, in order to induce highly competent persons to serve the Company as directors or
May 5, 2015	CORRESP	EndoChoice Holdings ESP King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M.
May 5, 2015	EX-10.22	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Form of Incentive Stock Option Agreement Exhibit 10.22 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Form of Incentive Stock Option Agreement This Incentive Stock Option Agreement (this ?Agreement?) is made and entered into as of [DATE] (the ?Grant Date?) by and between EndoChoice Holdings, Inc., a Delaware corporation (the ?Company?) and [EMPLOYEE NAME] (the ?Participant?). Grant Date: Exercise Price per Share: Total Shar
May 5, 2015	EX-10.23	ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Form of Restricted Stock Award Agreement Exhibit 10.23 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Form of Restricted Stock Award Agreement This Restricted Stock Award Agreement (this ?Agreement?) is made and entered into as of [DATE] (the ?Grant Date?) by and between EndoChoice Holdings, Inc., a Delaware corporation (the ?Company?) and [EMPLOYEE NAME] (the ?Grantee?). WHEREAS, the Company has adopted the EndoChoice Hold
May 5, 2015	EX-3.1	FORM OF CERTIFICATE OF INCORPORATION ENDOCHOICE HOLDINGS, INC. ARTICLE I - NAME EXHIBIT 3.1 FORM OF CERTIFICATE OF INCORPORATION OF ENDOCHOICE HOLDINGS, INC. ARTICLE I - NAME The name of the corporation is EndoChoice Holdings, Inc. (the ?Corporation?). ARTICLE II - REGISTERED OFFICE AND AGENT The address of the Corporation?s registered office in the State of Delaware is [ ]. The name of the Corporation?s registered agent at such address is [ ]. ARTICLE III - PURPOSE The purpo
May 5, 2015	EX-3.2	FORM OF ENDOCHOICE HOLDINGS, INC. ARTICLE 1 - OFFICES EXHIBIT 3.2 FORM OF BYLAWS OF ENDOCHOICE HOLDINGS, INC. ARTICLE 1 - OFFICES Section 1.1. Registered Office. The registered office of EndoChoice Holdings, Inc., a Delaware corporation (the ?Corporation?), shall be in the County of New Castle, State of Delaware. Section 1.2. Other Offices. The Corporation may also have offices at such other places, either within or outside of the State of Delaware,
May 5, 2015	EX-10.27	EMPLOYMENT AGREEMENT Exhibit 10.27 EMPLOYMENT AGREEMENT Mr. Kevin Rubey 1199 Church Street Ventura, CA 93001 EndoChoice, Inc., a Delaware corporation (together with its subsidiaries and affiliates, the ?Company?), hereby enters into this Employment Agreement (the ?Agreement?) with you, Kevin Rubey (?you? or ?Executive?), effective as of February 18, 2013 (the ?Effective Date?). The Company and you agree as follows: 1.
May 5, 2015	EX-10.26	AMENDED AND RESTATED EMPLOYMENT AGREEMENT EXHIBIT 10.26 AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Agreement”) is made by and amongst ECPM Holdings, LLC (together with its subsidiaries and affiliates, the “Company”), having its principal offices at 11810 Wills Road, Alpharetta, GA 30005 USA, and David N. Gill (the “Executive”), effective as of May 1, 2015. WHEREAS, the Company desires t
May 5, 2015	EX-10.25	THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT EXHIBIT 10.25 THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT THIS THIRD AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this ?Agreement?) is made by and amongst ECPM Holdings, LLC (together with its subsidiaries and affiliates, the ?Company?), having its principal offices at 11810 Wills Road, Alpharetta, GA 30005 USA, and Mark G. Gilreath (the ?Executive?), effective as of May 1, 2015 and amends and r
May 5, 2015	EX-10.24	FORM OF ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN Effective as of , 2015 ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN TABLE OF CONTENTS ARTICLE I PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN 4 1.1. Purpose and Scope 4 ARTICLE EX-10.24 7 d829480dex1024.htm EX-10.24 Exhibit 10.24 FORM OF ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN Effective as of , 2015 ENDOCHOICE HOLDINGS, INC. EMPLOYEE STOCK PURCHASE PLAN TABLE OF CONTENTS ARTICLE I PURPOSE, SCOPE AND ADMINISTRATION OF THE PLAN 4 1.1. Purpose and Scope 4 ARTICLE II DEFINITIONS 4 2.1. “Agent” 4 2.2. “Administrator” 4 2.3. “Board” 4 2.4. “Code” 4 2.5. “Committ
May 5, 2015	EX-10.28	ENDOCHOICE HOLDINGS, INC. FORM OF OFFICER SEVERANCE BENEFIT PLAN SUMMARY PLAN DESCRIPTION EFFECTIVE , 2015 TABLE OF CONENTS Page Section 1. INTRODUCTION. 1 (a) ?Affiliate? 1 (b) ?Annual Base Salary? 1 (c) ?Board? 1 (d) ?Cause? 1 (e) ?Change in Contro EXHIBIT 10.28 ENDOCHOICE HOLDINGS, INC. FORM OF OFFICER SEVERANCE BENEFIT PLAN AND SUMMARY PLAN DESCRIPTION EFFECTIVE , 2015 TABLE OF CONENTS Page Section 1. INTRODUCTION. 1 (a) ?Affiliate? 1 (b) ?Annual Base Salary? 1 (c) ?Board? 1 (d) ?Cause? 1 (e) ?Change in Control? 2 (f) ?Closing Date? 2 (g) ?COBRA? 3 (h) ?Code? 3 (i) ?Company? 3 (j) ?Covered Period? 3 (k) ?Covered Termination? 3 (l) ?Eligibl
May 5, 2015	EX-10.29	FORM OF INDEMNIFICATION AGREEMENT Exhibit 10.29 FORM OF INDEMNIFICATION AGREEMENT This INDEMNIFICATION AGREEMENT, dated as of [ ], 2015 (this ?Agreement?), is made by and between ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?) and (?Indemnitee?). WHEREAS, Section 18-402 of the Delaware Limited Liability Company Act provides that the business and affairs of a limited liability company may be managed by or u
May 5, 2015	EX-10.31	FORM OF EMPLOYMENT COVENANTS AGREEMENT Exhibit 10.31 FORM OF EMPLOYMENT COVENANTS AGREEMENT This EMPLOYMENT COVENANTS AGREEMENT (the ?Agreement?) is made this day of , 201 , (the ?Effective Date?), between EndoChoice, Inc. (which together with its subsidiaries, its parent company, ECPM Holdings, LLC, and all ECPM Holdings, LLC direct and indirect subsidiaries, is hereinafter referred to as the ?Company?) and (?You? or ?Your?)(collectiv
May 5, 2015	EX-10.21	FORM OF ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Effective as of , 2015 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN TABLE OF CONTENTS ARTICLE I. ESTABLISHMENT; PURPOSES; AND DURATION 1 1.1. Establishment of the Pl Exhibit 10.21 FORM OF ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN Effective as of , 2015 ENDOCHOICE HOLDINGS, INC. 2015 OMNIBUS EQUITY INCENTIVE PLAN TABLE OF CONTENTS ARTICLE I. ESTABLISHMENT; PURPOSES; AND DURATION 1 1.1. Establishment of the Plan 1 1.2. Purposes of the Plan 1 1.3. Duration of the Plan 1 ARTICLE II. DEFINITIONS 1 2.1. ?Affiliate? 1 2.2. ?Applicable Exchange? 2 2
March 17, 2015	EX-10	ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Incentive Option Date Vesting Begins: Expiration Date: , 20 EXHIBIT 10.13 Option No. ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement (Employees) Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Incentive Option Date Vesting Begins: Expiration Date: , 20 THIS AGREEMENT (together with Schedule A attached hereto, this “Agreement”), made effective as of the day of , 200 (the “Grant Dat
March 17, 2015	EX-10	PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT Exhibit 10.11 PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT This is a PLAIN ENGLISH GROWTH CAPITAL LOAN AND SECURITY AGREEMENT dated as of February 18, 2014 by and between ENDOCHOICE, INC., a Delaware corporation (?EC INC?), ECPM HOLDINGS, LLC, a Delaware limited liability company (?HOLDINGS?), ENDOCHOICE INTERNATIONAL, LLC, a Georgia limited liability company (?EC INT?L?), ROBERT S. SM
March 17, 2015	COVER	March 17, 2015 SEC Letter King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M.
March 17, 2015	EX-10	INVESTOR RIGHTS AGREEMENT EX-10.2 EXHIBIT 10.2 INVESTOR RIGHTS AGREEMENT THIS INVESTOR RIGHTS AGREEMENT (this “Agreement”) is made as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the “Company”), Avraham Levy (“Levy”) and the Persons listed on the Schedule of Major Members attached hereto (each, a “Major Member” and collectively, the “Major Members”). WHEREAS, the Company and ce
March 17, 2015	EX-10	SECOND LOAN MODIFICATION AND WAIVER AGREEMENT EXHIBIT 10.9 SECOND LOAN MODIFICATION AND WAIVER AGREEMENT This Second Loan Modification and Waiver Agreement (this ?Loan Modification Agreement?) is entered into as of July 24, 2014 by and between (i) SILICON VALLEY BANK, a California corporation (?Bank?), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (?Holdings?), (iii) ENDOCHOICE, INC., a Delaware corporation (?EndoChoice?), and
March 17, 2015	EX-10	THIRD LOAN MODIFICATION AND WAIVER AGREEMENT EXHIBIT 10.10 THIRD LOAN MODIFICATION AND WAIVER AGREEMENT This Third Loan Modification and Waiver Agreement (this “Loan Modification Agreement”) is entered into as of December 31, 2014 by and between (i) SILICON VALLEY BANK, a California corporation (“Bank”), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), (iii) ENDOCHOICE, INC., a Delaware corporation (“EndoChoice”),
March 17, 2015	EX-10	REGISTRATION AGREEMENT EXHIBIT 10.3 REGISTRATION AGREEMENT THIS REGISTRATION AGREEMENT (this ?Agreement?) is made as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware corporation (the ?Company?), the Persons listed on the Schedule of Investors attached hereto (each, an ?Investor? and collectively, the ?Investors? and the Persons listed on the Schedule of Other Holders attached hereto (each, an ?Other Holde
March 17, 2015	EX-10	FIRST AMENDMENT REGISTRATION AGREEMENT EXHIBIT 10.4 FIRST AMENDMENT TO REGISTRATION AGREEMENT This First Amendment to Registration Agreement (this ?Amendment?), is made and entered into effective as of October 30, 2014 (the ?Effective Date?), and amends that certain Registration Agreement, dated as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), and the other parties thereto (t
March 17, 2015	EX-10	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN 102 Capital Gains Track Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units EXHIBIT 10.20 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN 102 Capital Gains Track Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units THIS INCENTIVE UNIT AWARD AGREEMENT (the “Agreement”), made effective as of the day of , 20 (the “Grant Date”), between ECPM HOLDINGS, LLC, a Delaware limited liability company (the “Company”),
March 17, 2015	DRS/A	Confidential Draft Submission No. 3 as submitted confidentially with the Securities and Exchange Commission on March 17, 2015. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all informati DRS/A 1 filename1.htm Table of Contents Confidential Draft Submission No. 3 as submitted confidentially with the Securities and Exchange Commission on March 17, 2015. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMISSIO
March 17, 2015	EX-11	ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement (Non-Employee Directors) Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Nonqualified Option Date Vesting Begins: Expiration EXHIBIT 10.14 Option No. ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN Stock Option Agreement (Non-Employee Directors) Name of Participant: Grant Date: , 200 Number of Shares Subject to Option: Option Price: $ Type of Option: Nonqualified Option Date Vesting Begins: Expiration Date: , 20 THIS AGREEMENT (together with Schedule A attached hereto, this ?Agreement?), made effective as of the day of , 200
March 17, 2015	EX-10	FIRST AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN EXHIBIT 10.16 FIRST AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN THIS FIRST AMENDMENT, is made by ECPM Holdings, LLC, a Delaware limited liability company (the “Company”), effective as of the 9th day of September, 2013, to the Company’s 2013 Incentive Unit Plan, dated effective as of January 11, 2013 (the “Plan”). Capitalized terms used herein and not otherwise defined shall have the m
March 17, 2015	EX-10	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units EXHIBIT 10.18 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units THIS INCENTIVE UNIT AWARD AGREEMENT (the ?Agreement?), made effective as of the day of , 20 (the ?Grant Date?), between ECPM HOLDINGS, LLC, a Delaware limited liability company (the ?Company?), and , an Employee, Direc
March 17, 2015	EX-10	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Section 3(i) Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units EXHIBIT 10.19 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN Section 3(i) Incentive Unit Award Agreement Name of Participant: Grant Date: Number of Incentive Units Subject to Award: Incentive Units THIS INCENTIVE UNIT AWARD AGREEMENT (the “Agreement”), made effective as of the day of , 20 (the “Grant Date”), between ECPM HOLDINGS, LLC, a Delaware limited liability company (the “Company”), and , a Con
March 17, 2015	EX-10	SECOND AMENDMENT REGISTRATION AGREEMENT EXHIBIT 10.5 SECOND AMENDMENT TO REGISTRATION AGREEMENT This Second Amendment to Registration Agreement (this “Amendment”), is made and entered into effective as of March 4, 2015 (the “Effective Date”), and amends that certain Registration Agreement, dated as of January 4, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the “Company”), and the other parties thereto, as
March 17, 2015	EX-10	FIRST LOAN MODIFICATION AND WAIVER AGREEMENT EXHIBIT 10.8 FIRST LOAN MODIFICATION AND WAIVER AGREEMENT This First Loan Modification and Waiver Agreement (this “Loan Modification Agreement”) is entered into as of March 25, 2014 by and between (i) SILICON VALLEY BANK, a California corporation (“Bank”), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (“Holdings”), (iii) ENDOCHOICE, INC., a Delaware corporation (“EndoChoice”), (iv)
March 17, 2015	EX-10	VOTING AGREEMENT EXHIBIT 10.6 VOTING AGREEMENT THIS VOTING AGREEMENT is made and entered into as of this 4th day of January, 2013, by and among ECPM Holdings, LLC, a Delaware limited liability company (the ?Company?), Council Capital II, LP, Envest III, LLC, River Cities Capital Fund IV, L.P., and River Cities Capital Fund IV (N.Q.P.), L.P. (each a ?Class B Holder? and together with any subsequent transferees, who
March 17, 2015	EX-10	LOAN AND SECURITY AGREEMENT Exhibit 10.7 LOAN AND SECURITY AGREEMENT THIS LOAN AND SECURITY AGREEMENT (this ?Agreement?) dated as of September 9, 2013 (the ?Effective Date?) between (i) SILICON VALLEY BANK, a California corporation (?Bank?), (ii) ECPM HOLDINGS, LLC, a Delaware limited liability company (?Holdings?) and (iii) ENDOCHOICE, INC., a Delaware corporation (?EndoChoice?), ENDOCHOICE INTERNATIONAL, LLC, a Georgia lim
March 17, 2015	EX-10	SECOND AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN EXHIBIT 10.17 SECOND AMENDMENT TO ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN THIS SECOND AMENDMENT, is made by ECPM Holdings, LLC, a Delaware limited liability company (the “Company”), effective as of the 6th day of August, 2014, to the Company’s 2013 Incentive Unit Plan, as amended through September 9, 2013 (the “Plan”). Capitalized terms used herein and not otherwise defined shall have the mean
March 17, 2015	EX-10	ECPM HOLDINGS, LLC A Delaware Limited Liability Company SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of March 4, 2015 EXHIBIT 10.1 ECPM HOLDINGS, LLC A Delaware Limited Liability Company SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT Dated as of March 4, 2015 THE MEMBERSHIP UNITS REPRESENTED BY THIS SECOND AMENDED AND RESTATED LIMITED LIABILITY COMPANY AGREEMENT HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED, OR UNDER ANY OTHER APPLICABLE FEDERAL OR STATE SECU
March 17, 2015	EX-10	ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN EXHIBIT 10.15 ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN ECPM HOLDINGS, LLC 2013 INCENTIVE UNIT PLAN 1. Definitions In addition to other terms which may be defined herein, the following terms shall have the meanings given below: (a) Administrator means the Board of the Company, and, upon its delegation of all or part of the authority to administer the Plan to the Committee, the Committee. (b) Aff
March 17, 2015	EX-10	ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed By ECPM Holdings, LLC and Amended and Restated Effective January 4 EXHIBIT 10.12 ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed by ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) ENDOCHOICE, INC. 2007 STOCK INCENTIVE PLAN (As Assumed By ECPM Holdings, LLC and Amended and Restated Effective January 4, 2013) 1. Definitions In addition to other terms defined herein, the following terms shall have the meanings given below: (a) Administr
February 17, 2015	COVER	GI / EndoChoice Holdings Inc. COVER - - SEC Response Letter King & Spalding LLP 1180 Peachtree Street Atlanta, Georgia 30309 Main: (404) 572-4600 Fax: (404) 572-5100 Keith M.
February 17, 2015	EX-16	WINDHAM BRANNON Exhibit 16.1 Exhibit 16.1 WINDHAM BRANNON January 9, 2015 Securities and Exchange Commission Mail Stop 8031 100 F Street, NE Washington, DC 20549 Ladies and Gentlemen: We were previously principal accountants for EndoChoice, Inc. and Subsidiaries (predecessor to ECPM Holdings, LLC) and, under the date of July 30, 2013, we reported on the consolidated financial statements of EndoChoice, Inc. and Su
February 17, 2015	DRS/A	GI / EndoChoice Holdings Inc. DRS/A - - DRS/A 1 filename1.htm Table of Contents Confidential Draft Submission No. 2 as submitted confidentially with the Securities and Exchange Commission on February 17, 2015. This draft registration statement has not been publicly filed with the Securities and Exchange Commission and all information herein remains strictly confidential. Registration No. 333- UNITED STATES SECURITIES AND EXCHANGE COMMIS
February 17, 2015	DRS/A	GI / EndoChoice Holdings Inc. DRS/A - - begin 644 829480.pdf M)5!$1BTQ+C,-)>+CS],-"C$Q,3$@,"!O8FH-/#PO3&EN96%R:7IE9"`Q+TP@ M.#<@ M,3@+@E(.(,B%``$DSS@83\ M31"W$T@PP`L8Q`L@8@X@J(NQ:D;@&0R/[)P,3(\@S( M8F!@I#KQ]J]P`!!@!:IA)=#0IE;F1S=')E86T-96YD;V)J#7-T87)T>')E M9@T,`T)25%3T8-"B`@("`@("`-"C$Q-3(@,"!O8FH-/#PO0B`S,C,V+T9I M;'1EJ+J$0T%EL0HT!UH;00'EH@;0P2 MTBB/K9H`"K'\4'P0-4BY]Z994L3?QEZ4WFYMY[OG/.=[Y[-C.+$'(CI$20 M!O-!Y$.9X4,JGJ()CCZ!Z,97M#
January 9, 2015	EX-21	List of Subsidiaries of ECPM Holdings, LLC Subsidiary Jurisdiction of Incorporation or Organization EndoChoice, Inc. Delaware EndoChoice GmbH Germany EndoChoice Innovation Center Ltd. Israel Robert S. Smith, M.D., Inc. Georgia EndoChoice Israel Ltd. EX-21.1 Exhibit 21.1 List of Subsidiaries of ECPM Holdings, LLC Subsidiary Jurisdiction of Incorporation or Organization EndoChoice, Inc. Delaware EndoChoice GmbH Germany EndoChoice Innovation Center Ltd. Israel Robert S. Smith, M.D., Inc. Georgia EndoChoice Israel Ltd. Israel
January 9, 2015	DRS	GI / EndoChoice Holdings Inc. DRS - - S-1 Table of Contents Index to Financial Statements As submitted confidentially with the Securities and Exchange Commission on January 9, 2015.

GI / EndoChoice Holdings Inc. - Документы SEC, Годовой отчет, Доверенное заявление

Основная статистика

SEC Filings

SEC Filings (Chronological Order)